Stephen M. Dorton - Oct 25, 2022 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Financial Officer
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Oct 25, 2022
Transactions value $
-$137,722
Form type
4
Date filed
10/27/2022, 09:17 PM
Previous filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +38.4K +20.59% $0.00 225K Oct 25, 2022 Direct F1
transaction ENFN Class A Common Stock Tax liability -$138K -10.4K -4.6% $13.30 215K Oct 25, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").
F2 Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Shares to the reporting person.